<PAGE>
EXHIBIT 23.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement on
Form S-8 pertaining to the common stock issuable upon exercise of options
assumed by Maxim Pharmaceuticals, Inc. originally granted under the Cytovia,
Inc. 1998 Equity Incentive Plan and the Cytovia 2000 Equity Incentive Plan
and common stock issuable pursuant to Maxim Pharmaceuticals, Inc.'s 2000
Nonstatutory Stock Option Plan of our report dated March 24, 2000, with
respect to the financial statements of Cytovia, Inc. included in the Current
Report on Form 8-K filed June 30, 2000 and Current Report on Form 8-K/A filed
August 22, 2000 of Maxim Pharmaceuticals, Inc. as filed with the Securities
and Exchange Commission.
/s/ ERNST & YOUNG LLP
San Diego, California
September 11, 2000
